Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738276) titled 'Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity' on July 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Shahid Beheshti University of Medical Sciences
Condition:
Heart Failure and Reduced Ejection Fraction
Obesity & Overweight
Tirzepatide
Intervention:
Drug: Tirzepatide
Recruitment Status: Not recruiting
...